Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Loss of the cortisol response to naltrexone in Alzheimer's disease.
Pomara N, Stanley M, Rhiew HB, Bagne CA, Deptula D, Galloway MP, Tanimoto K, Verebey K, Tamminga CA. Pomara N, et al. Biol Psychiatry. 1988 Apr 1;23(7):726-33. doi: 10.1016/0006-3223(88)90057-1. Biol Psychiatry. 1988. PMID: 3285899 Free article. Clinical Trial.
Pathophysiology of Alzheimer's disease.
Imbimbo BP, Lombard J, Pomara N. Imbimbo BP, et al. Among authors: pomara n. Neuroimaging Clin N Am. 2005 Nov;15(4):727-53, ix. doi: 10.1016/j.nic.2005.09.009. Neuroimaging Clin N Am. 2005. PMID: 16443487 Review.
322 results